|1.||Zetterberg, Henrik: 2 articles (01/2014 - 04/2010)|
|2.||Rosengren, Lars: 2 articles (01/2014 - 04/2010)|
|3.||Gisslén, Magnus: 1 article (01/2014)|
|4.||Nilsson, Staffan: 1 article (01/2014)|
|5.||Mellberg, Tomas: 1 article (01/2014)|
|6.||Hagberg, Lars: 1 article (01/2014)|
|7.||Fuchs, Dietmar: 1 article (01/2014)|
|8.||Price, Richard W: 1 article (01/2014)|
|9.||Jessen Krut, Jan: 1 article (01/2014)|
|10.||Harder, Jonas: 1 article (04/2013)|
05/23/2000 - "To investigate the CSF levels of tau and the light neurofilament protein (NFL) in patients with frontotemporal dementia (FTD) and other common dementia disorders as well as normal control subjects. "
01/01/2014 - "With a cross-sectional design, CSF concentrations of neurofilament protein light (NFL) (marker of neuronal injury), neopterin (intrathecal immunoactivation) and CSF/Plasma albumin ratio (blood-brain barrier integrity) were analyzed on CSF from 252 HIV-infected patients, subdivided into untreated neuroasymptomatics (n = 200), HIV-associated dementia (HAD) (n = 14) and on combinations antiretroviral treatment (cART) (n = 85), and healthy controls (n = 204). "
|5.||Major Depressive Disorder (Major Depressive Disorders)
04/30/2010 - "In light of our previous observation of higher levels of cerebrospinal fluid (CSF) amyloid beta-42 (Abeta42) and CSF/serum albumin ratio in major depressive disorder (MDD), we analyzed two additional CSF biomarkers reflecting neurodegeneration-neurofilament protein light (NFL) and glial fibrillary acidic protein (GFAp)-in relationship to prevalent geriatric depression. "
|2.||Biological Markers (Surrogate Marker)
|5.||Glial Fibrillary Acidic Protein
|6.||Amyloid (Amyloid Fibrils)